{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:12 23:20:22.323",
            "Expression": "mesenchymal ADSTEM Inj.",
            "NStudiesAvail": 430639,
            "NStudiesFound": 3,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 3,
            "FieldList": [
                  "BriefSummary",
                  "BriefTitle",
                  "CentralContactEMail",
                  "CentralContactName",
                  "CentralContactPhone",
                  "CentralContactPhoneExt",
                  "CentralContactRole",
                  "CollaboratorClass",
                  "CollaboratorName",
                  "CompletionDate",
                  "CompletionDateType",
                  "Condition",
                  "ConditionAncestorId",
                  "ConditionAncestorTerm",
                  "ConditionBrowseBranchAbbrev",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "BriefSummary": [
                              "This study aims to evaluate safety, tolerance, and efficacy in subjects with over moderately subacute and chronic atopic dermatitis after an intravenous injection of autologous mesenchymal stem cells. The study is composed of two steps. Step 1 is to determine clinically proper dose capacity of the ADSTEM Inj. and step 2 is to evaluate exploratory efficacy of the ADSTEM Inj. at the proper dose."
                        ],
                        "BriefTitle": [
                              "Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "December 2017"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Atopic Dermatitis"
                        ],
                        "ConditionAncestorId": [
                              "D000012871",
                              "D000012873",
                              "D000030342",
                              "D000017443",
                              "D000006969",
                              "D000006967",
                              "D000007154"
                        ],
                        "ConditionAncestorTerm": [
                              "Skin Diseases",
                              "Skin Diseases, Genetic",
                              "Genetic Diseases, Inborn",
                              "Skin Diseases, Eczematous",
                              "Hypersensitivity, Immediate",
                              "Hypersensitivity",
                              "Immune System Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC16",
                              "BC17",
                              "BC20",
                              "All",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT02888704"
                        ]
                  },
                  {
                        "Rank": 2,
                        "BriefSummary": [
                              "This study aims to evaluate safety in subjects with over moderately subacute and chronic atopic dermatitis after an intravenous injection of ADSTEM Inj. Since this is an observational study of patients participated in Phase 1 clinical trials, no drug is administered in this study."
                        ],
                        "BriefTitle": [
                              "Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "August 16, 2022"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Atopic Dermatitis"
                        ],
                        "ConditionAncestorId": [
                              "D000012871",
                              "D000012873",
                              "D000030342",
                              "D000017443",
                              "D000006969",
                              "D000006967",
                              "D000007154"
                        ],
                        "ConditionAncestorTerm": [
                              "Skin Diseases",
                              "Skin Diseases, Genetic",
                              "Genetic Diseases, Inborn",
                              "Skin Diseases, Eczematous",
                              "Hypersensitivity, Immediate",
                              "Hypersensitivity",
                              "Immune System Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC16",
                              "BC17",
                              "BC20",
                              "All",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT03252340"
                        ]
                  },
                  {
                        "Rank": 3,
                        "BriefSummary": [
                              "A Multicenter, Randomized, Single-Blind, Phase \u2161 Clinical Trial and Open Label Long-term Observation Study of ADSTEM Inj. to Evaluate the Safety and Efficacy in Patients with Moderate to Severe Subacute and Chronic Atopic Dermatitis.\n\nThe aim of this study is to evaluate the safety and efficacy of ADSTEM Inj. against Placebo in the treatment of atopic dermatitis in patients with moderate to severe acute and chronic atopic."
                        ],
                        "BriefTitle": [
                              "Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis"
                        ],
                        "CentralContactEMail": [
                              "seokehl@ehlbio.com"
                        ],
                        "CentralContactName": [
                              "junseok seo"
                        ],
                        "CentralContactPhone": [
                              "+82.70.5038.1940"
                        ],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "May 31, 2027"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Atopic Dermatitis"
                        ],
                        "ConditionAncestorId": [
                              "D000012871",
                              "D000012873",
                              "D000030342",
                              "D000017443",
                              "D000006969",
                              "D000006967",
                              "D000007154"
                        ],
                        "ConditionAncestorTerm": [
                              "Skin Diseases",
                              "Skin Diseases, Genetic",
                              "Genetic Diseases, Inborn",
                              "Skin Diseases, Eczematous",
                              "Hypersensitivity, Immediate",
                              "Hypersensitivity",
                              "Immune System Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC16",
                              "BC17",
                              "BC20",
                              "All",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT04137562"
                        ]
                  }
            ]
      }
}